1
|
Noviana E, Siswanto S, Budi Hastuti AAM. Advances in Nanomaterial-Based Biosensors for Determination of Glycated Hemoglobin. Curr Top Med Chem 2022; 22:CTMC-EPUB-126335. [PMID: 36111762 DOI: 10.2174/1568026622666220915114646] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2022] [Revised: 06/02/2022] [Accepted: 08/01/2022] [Indexed: 11/22/2022]
Abstract
Diabetes is a major public health burden whose prevalence has been steadily increasing over the past decades. Glycated hemoglobin (HbA1c) is currently the gold standard for diagnostics and monitoring glycemic control in diabetes patients. HbA1c biosensors are often considered to be cost-effective alternatives for smaller testing laboratories or clinics unable to access other reference methods. Many of these sensors deploy nanomaterials as recognition elements, detection labels, and/or transducers for achieving sensitive and selective detection of HbA1c. Nanomaterials have emerged as important sensor components due to their excellent optical and electrical properties, tunable morphologies, and easy integration into multiple sensing platforms. In this review, we discuss the advantages of using nanomaterials to construct HbA1c sensors and various sensing strategies for HbA1c measurements. Key gaps between the current technologies with what is needed moving forward are also summarized.
Collapse
Affiliation(s)
- Eka Noviana
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
- Research Center for Drug Targeting and Personalized Medicine, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
| | - Soni Siswanto
- Research Center for Drug Targeting and Personalized Medicine, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
| | - Agustina Ari Murti Budi Hastuti
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
- Center of Excellence Institute for Halal Industry and Systems (PUI-PT IHIS), Universitas Gadjah Mada, Indonesia
| |
Collapse
|
2
|
Pulunggono HB, Siswanto S, Mubarok H, Widiastuti H, Tambusai N, Zulfajrin M, Anwar S, Taniwiryono D, Sumawinata B, Sabiham S. Seasonal litter contribution to total peat respiration from drained tropical peat under mature oil palm plantation. J Degrade Min Land Manage 2022. [DOI: 10.15243/jdmlm.2022.092.3247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The amount of CO2 gas emissions in drained peatland for oil palm cultivation has been widely reported. However, the research addressing the contribution of litter respiration to peat and total respiration and its relationship with several environmental factors is found rare. The aim of this study was to measure peat and heterogeneous litter respiration of drained tropical peat in one year at a distance of 2.25 m and 4.50 m from mature oil palm trees of 14 years using the chamber method (Licor Li-830). In addition to CO2 efflux, we measured other environmental parameters, including peat temperature (10 cm depth), air temperature, groundwater table (GWL), and rainfall. Results showed that the mean total peat respiration (Rt) was 12.06 g CO2 m-2day-1, which consisted of 68% (8.24 g CO2 m-2day-1) peat (Rp) and root (Rr) respiration and 32% (3.84 g CO2 m-2day-1) of litter respiration (Rl) at the distance of 2.25 m from the palm tree. Meanwhile, at a farther distance, the Rt was 12.49 g CO2m-2day-1, the contribution of Rp was 56% (6.78 g CO2 m-2day-1), and Rl was higher than the closest distance (46%; 5.71 g CO2 m-2day-1). Thus, one-year observation resulting the mean Rt and Rr was 0.07–0.08 Mg CO2 ha-1 day-1, while Rl was 0.04–0.06 Mg CO2 ha-1 day-1. The means of Rt, Rp, and Rl were significantly different in the dry season than those recorded in the rainy season. The climatic-related variable such as peat and air temperature were chiefly governing respiration in peat under mature oil palm plantation, whereas the importance of other variables present at particular conditions. This paper provides valuable information concerning respiration in peat, especially for litter contribution and its relationship with environmental factors in peatland, contributing to global CO2 emission.
Collapse
|
3
|
Siswanto S, Yamamoto H, Furuta H, Kobayashi M, Nagashima T, Kayanuma G, Nagayasu K, Imai Y, Kaneko S. Drug Repurposing Prediction and Validation From Clinical Big Data for the Effective Treatment of Interstitial Lung Disease. Front Pharmacol 2021; 12:635293. [PMID: 34621164 PMCID: PMC8490809 DOI: 10.3389/fphar.2021.635293] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Accepted: 09/06/2021] [Indexed: 11/13/2022] Open
Abstract
Interstitial lung diseases (ILDs) are a group of respiratory disorders characterized by chronic inflammation and fibrosis of the pulmonary interstitial tissues. Although the etiology of ILD remains unclear, some drug treatments are among the primary causes of ILD. In the present study, we analyzed the FDA Adverse Event Reporting System and JMDC Inc. insurance claims to identify a coexisting drug that reduced the incidence of ILD associated with the use of an anti-arrhythmic agent, amiodarone, and found that the thrombin inhibitor dabigatran prevented the amiodarone-induced ILD in both clinical datasets. In an experimental validation of the hypothesis, long-term oral treatment of mice with amiodarone caused a gradual decrease in body weight caused by respiratory insufficiency. In the lungs of amiodarone-treated mice, infiltration of macrophages was observed in parallel with a delayed upregulation of the platelet-derived growth factor receptor α gene. In contrast, co-treatment with dabigatran significantly attenuated these amiodarone-induced changes indicative of ILD. These results suggest that dabigatran is effective in preventing drug-induced ILD. This combinatorial approach of drug repurposing based on clinical big data will pave the way for finding a new treatment with high clinical predictability and a well-defined molecular mechanism.
Collapse
Affiliation(s)
- Soni Siswanto
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Hiroki Yamamoto
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Haruka Furuta
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Mone Kobayashi
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Takuya Nagashima
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Gen Kayanuma
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Kazuki Nagayasu
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Yumiko Imai
- Laboratory of Regulation of Intractable Infectious Diseases, National Institutes of Biomedical Innovation Health and Nutrition, Osaka, Japan
| | - Shuji Kaneko
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| |
Collapse
|
4
|
Nagaoka K, Nagashima T, Asaoka N, Yamamoto H, Toda C, Kayanuma G, Siswanto S, Funahashi Y, Kuroda K, Kaibuchi K, Mori Y, Nagayasu K, Shirakawa H, Kaneko S. Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist-induced orofacial dyskinesia. JCI Insight 2021; 6:145632. [PMID: 33857021 PMCID: PMC8262333 DOI: 10.1172/jci.insight.145632] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Accepted: 04/07/2021] [Indexed: 01/01/2023] Open
Abstract
Antipsychotics often cause tardive dyskinesia, an adverse symptom of involuntary hyperkinetic movements. Analysis of the US Food and Drug Administration Adverse Event Reporting System and JMDC insurance claims revealed that acetaminophen prevented the dyskinesia induced by dopamine D2 receptor antagonists. In vivo experiments further showed that a 21-day treatment with haloperidol increased the number of vacuous chewing movements (VCMs) in rats, an effect that was inhibited by oral acetaminophen treatment or intracerebroventricular injection of N-(4-hydroxyphenyl)-arachidonylamide (AM404), an acetaminophen metabolite that acts as an activator of the transient receptor potential vanilloid 1 (TRPV1). In mice, haloperidol-induced VCMs were also mitigated by treatment with AM404 applied to the dorsal striatum, an effect not seen in TRPV1-deficient mice. Acetaminophen prevented the haloperidol-induced decrease in the number of c-Fos+preproenkephalin+ striatal neurons in wild-type mice but not in TRPV1-deficient mice. Finally, chemogenetic stimulation of indirect pathway medium spiny neurons in the dorsal striatum decreased haloperidol-induced VCMs. These results suggest that acetaminophen activates the indirect pathway neurons by activating TRPV1 channels via AM404.
Collapse
Affiliation(s)
- Koki Nagaoka
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Takuya Nagashima
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Nozomi Asaoka
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.,Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Hiroki Yamamoto
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Chihiro Toda
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Gen Kayanuma
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Soni Siswanto
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Yasuhiro Funahashi
- Department of Cell Pharmacology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.,Research project for neural and tumor signaling, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| | - Keisuke Kuroda
- Department of Cell Pharmacology, Graduate School of Medicine, Nagoya University, Nagoya, Japan
| | - Kozo Kaibuchi
- Department of Cell Pharmacology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.,Research project for neural and tumor signaling, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| | - Yasuo Mori
- Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering and Faculty of Engineering, Kyoto University, Katsura Campus, Kyoto, Japan
| | - Kazuki Nagayasu
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Hisashi Shirakawa
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| | - Shuji Kaneko
- Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
| |
Collapse
|
5
|
Ghufron Chakim M, Mindari W, Siswanto S, Edi Sasongko P. Humic acid characterization in soil from various land uses in Tutur District, Pasuruan Regency of East Java. J Degrade Min Land Manage 2020. [DOI: 10.15243/jdmlm.2020.074.2279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
6
|
Agustini FD, Arozal W, Louisa M, Siswanto S, Soetikno V, Nafrialdi N, Suyatna F. Cardioprotection mechanism of mangiferin on doxorubicin-induced rats: Focus on intracellular calcium regulation. Pharm Biol 2016; 54:1289-1297. [PMID: 26440532 DOI: 10.3109/13880209.2015.1073750] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
CONTEXT The molecular mechanism of doxorubicin (DOX) cardiotoxicity involves overproduction of free radicals that leads to intracellular calcium dysregulation and apoptosis. Mangiferin (MGR), a naturally occurring glucosylxanthone, has antioxidant and cardioprotective properties. However, its cardioprotection mechanism has yet to be revealed. OBJECTIVE This study determines whether the cardioprotective effect of MGR is caused by its effect on intracellular calcium regulation. MATERIALS AND METHODS Male Sprague-Dawley rats were induced by DOX intraperitoneally with a total dose of 15 mg/kg bw. MGR was given orally at the doses of 30 and 60 mg/kg bw/d for seven consecutive weeks. The parameters examined were mRNA expression levels of proinflammatory cytokine gene (TNF-α), calcium regulatory gene (SERCA2a) and proapoptotic genes (caspase-9 and caspase-12), as well as cytosolic and mitochondrial calcium levels. RESULTS Treatment with MGR at 60 mg/kg bw/d significantly decreased the mRNA expression levels of TNF-α by 44.55% and caspase-9 by 52.79%, as well as the cytosolic calcium level by 24.15% (p < 0.05). SERCA2a and caspase-12 expressions were only slightly affected (27.27% increase and 24.85% decrease for SERCA2a and caspase-12, respectively, p > 0.05). Meanwhile, MGR 30 mg/kg bw/d gave insignificant results in all parameters. DISCUSSION AND CONCLUSION MGR protected against DOX-induced cardiac inflammation and apoptosis via down-regulation of proapoptotic and proinflammatory gene expressions, upregulation of SERCA2a gene expression, and normalization of cytosolic calcium level. Thus, the cardioprotective effect of MGR is at least in part due to the regulation of intracellular calcium homeostasis.
Collapse
Affiliation(s)
| | - Wawaimuli Arozal
- b Department of Pharmacology and Therapeutics , Faculty of Medicine, Universitas Indonesia , Central Jakarta , Indonesia
| | - Melva Louisa
- b Department of Pharmacology and Therapeutics , Faculty of Medicine, Universitas Indonesia , Central Jakarta , Indonesia
| | | | - Vivian Soetikno
- b Department of Pharmacology and Therapeutics , Faculty of Medicine, Universitas Indonesia , Central Jakarta , Indonesia
| | - Nafrialdi Nafrialdi
- b Department of Pharmacology and Therapeutics , Faculty of Medicine, Universitas Indonesia , Central Jakarta , Indonesia
| | - Franciscus Suyatna
- b Department of Pharmacology and Therapeutics , Faculty of Medicine, Universitas Indonesia , Central Jakarta , Indonesia
| |
Collapse
|
7
|
Siswanto S, Arozal W, Juniantito V, Grace A, Agustini FD, Nafrialdi. The Effect of Mangiferin Against Brain Damage Caused by Oxidative Stress and Inflammation Induced by Doxorubicin. HAYATI Journal of Biosciences 2016. [DOI: 10.1016/j.hjb.2016.02.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
8
|
Seidel K, Siswanto S, Fredrich M, Bouzrou M, Brunt ER, van Leeuwen FW, Kampinga HH, Korf HW, Rüb U, den Dunnen WFA. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation. Neuropathol Appl Neurobiol 2015; 42:153-66. [DOI: 10.1111/nan.12253] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2014] [Accepted: 05/14/2015] [Indexed: 01/19/2023]
Affiliation(s)
- K. Seidel
- Dr. Senckenbergisches Chronomedizinisches Institut; Goethe University; Frankfurt/Main Germany
| | - S. Siswanto
- Dr. Senckenbergisches Chronomedizinisches Institut; Goethe University; Frankfurt/Main Germany
| | - M. Fredrich
- Dr. Senckenbergisches Chronomedizinisches Institut; Goethe University; Frankfurt/Main Germany
| | - M. Bouzrou
- Dr. Senckenbergisches Chronomedizinisches Institut; Goethe University; Frankfurt/Main Germany
| | - E. R. Brunt
- Department of Neurology; University of Groningen; Groningen The Netherlands
| | - F. W. van Leeuwen
- Department of Neuroscience; Maastricht University; Maastricht The Netherlands
| | - H. H. Kampinga
- Cell Biology, Radiation and Stress Cell Biology; University of Groningen; Groningen The Netherlands
| | - H. -W. Korf
- Dr. Senckenbergisches Chronomedizinisches Institut; Goethe University; Frankfurt/Main Germany
| | - U. Rüb
- Dr. Senckenbergisches Chronomedizinisches Institut; Goethe University; Frankfurt/Main Germany
| | - W. F. A. den Dunnen
- Department of Pathology and Medical Biology; University Medical Center Groningen; University of Groningen; Groningen The Netherlands
| |
Collapse
|